Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treprostinil in Reducing Ischemia-Reperfusion Injury During De Novo Adult Kidney Transplantation
NCT04005469Phase 2Recruiting
- Sponsor
- Rhode Island Hospital
- Start
- Nov 2020
- Primary completion
- Jun 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of treprostinil in ischemia-reperfusion injury (IRI), delayed graft function (DGF), sponsored by Rhode Island Hospital. Started Nov 2020; status: recruiting.
02
Drugs
treprostinil
03
Conditions
ischemia-reperfusion injury (IRI)delayed graft function (DGF)
Beyond the preview
Go deeper on NCT04005469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04005469.